[Consumption of narcotics, substances assimilated to narcotics and psychotropic drugs in health establishments: Profile of a hospital from France and a hospital from Quebec]

Ann Pharm Fr. 2022 May;80(3):312-326. doi: 10.1016/j.pharma.2021.08.003. Epub 2021 Aug 20.
[Article in French]

Abstract

Objectives: The objective was to describe the trends in the consumption of narcotic drugs, substances related to narcotic drugs (SAS) and psychotropic drugs between a French hospital and a Quebec hospital between 2013 and 2017.

Methods: This is a retrospective descriptive study. The consumption data was obtained from the pharmacy management software and was extracted by financial year (January 1st, 2013 to December 31st, 2017 for the French hospital and April 1st, 2013 to March 31st, 2018 for the Quebec hospital). For each drug considered to be narcotics, SAS and psychotropic drugs in France or subject to the legislation on designated substances in Quebec, we identified the quantities consumed from 2013 to 2017. The data werepresented according to the following therapeutic classes: opioids (N02A), other analgesics (N02B), anxiolytics (N05B), hypnotics and sedatives (N05C), general anesthetics (N01A), psychostimulants (N06B), androgens (G03B) and antagonists peripheral opioid receptors (A06A). The data were expressed as a defined daily dose (DDJ) for 1000 patient-days (PDs).

Results: In the French hospital, the consumption of narcotics, SAS and psychotropic drugs varied from 676 to 560 DDJ per 1000 PDs between 2013 and 2017. While it varied from 1019 to 756 DDJ per 1000 PDs between 2013 and 2017 in the Quebec hospital. In 2017, the most widely used therapeutic classes in French hospitals were, in decreasing order, anxiolytics (211 DDJ per 1000 PDs) (i.e. alprazolam), opioids (205 DDJ per 1000 PDs) (i.e. tramadol, morphine injectable) and hypnotics and sedatives (64 DDJ per 1000 PDs) (i.e. midazolam injectable). In Quebec hospitals, the three therapeutic classes the most used in 2017 were, in decreasing order, opioids (314 DDJ per 1000 PDs) (i.e. hydromorphone injectable, morphine injectable), anxiolytics (221 DDJ per 1000 PDs) (i.e. clobazam) and hypnotics and sedatives (108 DDJ per 1000 PDs) (i.e. midazolam injectable).

Conclusion: This study notes a decrease in the consumption of opioids and other substances in both the French and Quebec establishments between 2013-2017. More work is needed to better describe the differences observed between the profile of each establishment. This is why monitoring consumption trends, therapeutic indications and preventive measures are essential.

Keywords: Bon usage; Hospital pharmacy practice; Narcotics; Pharmacie hospitalière; Psychotropes; Psychotropic drugs; Stupéfiants; Substances désignées; Surveillance; Targeted substances.

MeSH terms

  • Analgesics, Opioid
  • Anti-Anxiety Agents*
  • France / epidemiology
  • Hospitals
  • Humans
  • Hypnotics and Sedatives
  • Midazolam
  • Morphine Derivatives
  • Narcotics
  • Psychotropic Drugs / therapeutic use
  • Quebec / epidemiology
  • Retrospective Studies

Substances

  • Analgesics, Opioid
  • Anti-Anxiety Agents
  • Hypnotics and Sedatives
  • Morphine Derivatives
  • Narcotics
  • Psychotropic Drugs
  • Midazolam